Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Lower fasting insulin and C-peptide Reduced HOMA2-IR (insulin resistance) Improved lipid profile (triglycerides) Raised adiponectin, lowered leptin Better glucose control Liver Fat Retatrutide reduced liver fat content by as much as 76% for MASLD patients, with the majority of the change occurring during the first 24 weeks
16 : 417422 Esposti D, Mariani M, Demartini G, Lucini V, Fraschini F, Mancia M
This includes access to state-of-the-art medical technologies, expert medical advice, and a supportive community that encourages sustainable health habits.
Retatrutide 12 mg produced 24.2% mean body-weight loss at 48 weeks in the Phase 2 obesity trial (Jastreboff et al., NEJM 2023) [3][4]
US$ 27.00
US$ 24.12
US$ 28.66
US$ 23.59
US$ 24.33
US$ 22.05
US$ 22.43
